Common Contracts
6 similar Clinical Trial Agreement contracts
CLINICAL TRIAL AGREEMENT FOR THE DRUG(S) “__________” BETWEENClinical Trial Agreement • April 15th, 2024
Istituto clinico Humanitas – Humanitas Mirasole S.p.A. shareholder company (hereinafter the “Entity”), headquartered in Rozzano (Milan) Zip code 20089, Via Alessandro Manzoni 56, Tax Code 10125410158, VAT no. 10982360967 , through its Legal Representative Mr. Luciano Ravera , in his capacity as managing director with the powers to enter into this agreement
AGREEMENT FOR THE CARRYING OUT OF THE CLINICAL TRIAL ENTITLED“_________________________________"Clinical Trial Agreement • February 5th, 2023
Istituto clinico Humanitas – Humanitas Mirasole S.p.A. shareholder company (hereinafter also Entity) with registered office in Rozzano (Milan) Zip code 20089, Via Alessandro Manzoni 56, Tax n. 10125410158, VAT n. 10982360967, hereinafter represented by Mr. Luciano Ravera in his quality of managing director
CLINICAL TRIAL AGREEMENT FOR THE DRUG(S) “ ”Clinical Trial Agreement • November 14th, 2022
, Tax Code and VAT no. , through its Legal Representative , in her/his capacity as (indicate whether Director General, CEO, Extraordinary Commissioner, etc.) (if applicable: who granted Ms./Mr. (name and position of signatory) with the powers to enter into this agreement
AGREEMENT FOR THE CARRYING OUT OF THE CLINICAL TRIAL ENTITLED“_________________________________"Clinical Trial Agreement • November 14th, 2022
Istituto Clinico Humanitas – Humanitas Mirasole S.p.A. shareholder company (hereinafter also Entity) with registered office in Rozzano (Milan) Zip code 20089, Via Alessandro Manzoni 56, Tax n. 10125410158, VAT n. 10982360967, hereinafter represented by Mr. Luciano Ravera in his quality of managing director
CLINICAL TRIAL AGREEMENT FOR THE DRUG(S) “__________” BETWEENClinical Trial Agreement • November 4th, 2022
_________ (indicate name of Healthcare Facility) (hereinafter the “Entity”), headquartered in _______, Tax Code and VAT no. _________, through its Legal Representative _________, in her/his capacity as _________ (indicate whether Director General, CEO, Extraordinary Commissioner, etc.) (if applicable: who granted Ms./Mr. _________ (name and position of signatory) with the powers to enter into this agreement
CLINICAL TRIAL AGREEMENT FOR THE DRUG(S) “__________” BETWEENClinical Trial Agreement • November 4th, 2022
Fondazione IRCCS San Gerardo dei Tintori (hereinafter the “Entity"), headquartered in via Pergolesi 33, 20900 Monza (MB), tax code and VAT no. 12698710964, through its Legal Representative Dr. Claudio Cogliati in his capacity of President of the Board of Directors who, by resolution n° 17 of 27.03.2023, delegates the signing of this contract to the General Director, Dr. Silvano Casazza
